Free Trial
OTCMKTS:CLPBY

Coloplast A/S (CLPBY) Stock Price, News & Analysis

Coloplast A/S logo
$10.65 +0.03 (+0.28%)
As of 04/17/2025 03:58 PM Eastern

About Coloplast A/S Stock (OTCMKTS:CLPBY)

Key Stats

Today's Range
$10.51
$10.98
50-Day Range
$9.87
$11.32
52-Week Range
$9.67
$14.14
Volume
100,375 shs
Average Volume
208,544 shs
Market Capitalization
N/A
P/E Ratio
33.28
Dividend Yield
2.82%
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Receive CLPBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

CLPBY Stock News Headlines

Coloplast A/S (CLPBF) Q1 2025 Earnings Call Transcript
2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisis
What's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot-com bust, worse than the COVID crash, and even worse than the Great Depression. What's coming, he says, could soon crash the market by 50% or more – and keep it down for 10, 20, or even 30 years.
Coloplast A/S (CLPBF) Q4 2024 Earnings Call Transcript
Coloplast A/S - Financial Calendar 2024-25
See More Headlines

CLPBY Stock Analysis - Frequently Asked Questions

Coloplast A/S's stock was trading at $10.86 at the beginning of 2025. Since then, CLPBY stock has decreased by 1.9% and is now trading at $10.65.
View the best growth stocks for 2025 here
.

Coloplast A/S (OTCMKTS:CLPBY) announced its quarterly earnings data on Tuesday, February, 4th. The company reported $0.07 EPS for the quarter, missing analysts' consensus estimates of $0.08 by $0.01. Coloplast A/S had a trailing twelve-month return on equity of 28.60% and a net margin of 17.81%.

Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
2/04/2025
Today
4/18/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CLPBY
Previous Symbol
NASDAQ:CLPBY
Fax
N/A
Employees
16,875
Year Founded
1954

Profitability

Trailing P/E Ratio
33.28
Forward P/E Ratio
34.35
P/E Growth
3.08
Net Income
$734.56 million
Pretax Margin
23.66%

Debt

Sales & Book Value

Annual Sales
$3.93 billion
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.91

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:CLPBY) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners